| 000 | 01841 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513040550.0 | ||
| 264 | 0 | _c19931214 | |
| 008 | 199312s 0 0 eng d | ||
| 022 | _a0007-1188 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.1993.tb13769.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFan, T P | |
| 245 | 0 | 0 |
_aStimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cSep 1993 |
||
| 300 |
_a43-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_a6-Ketoprostaglandin F1 alpha _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aHistamine _xphysiology |
| 650 | 0 | 4 |
_aHistamine H1 Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aHistamine H2 Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aIndomethacin _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 |
_aInterleukin-1 _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeovascularization, Pathologic _xpathology |
| 650 | 0 | 4 | _aNeurokinin-1 Receptor Antagonists |
| 650 | 0 | 4 |
_aPlatelet Activating Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProstaglandins _xphysiology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptors, Interleukin-1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aReceptors, Neurokinin-1 _xphysiology |
| 650 | 0 | 4 |
_aRegional Blood Flow _xdrug effects |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 650 | 0 | 4 | _aXenon Radioisotopes |
| 700 | 1 | _aHu, D E | |
| 700 | 1 | _aGuard, S | |
| 700 | 1 | _aGresham, G A | |
| 700 | 1 | _aWatling, K J | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 110 _gno. 1 _gp. 43-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.1993.tb13769.x _zAvailable from publisher's website |
| 999 |
_c7692702 _d7692702 |
||